Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-02-21 @ 8:40 AM
Study NCT ID:
NCT02505269
Status:
COMPLETED
Last Update Posted:
2020-08-24
First Post:
2015-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma
Sponsor:
Organization: